Lytix Biopharma - Private Placement & subsequent listing on Euronext Growth Oslo - NOK 225m

Arctic acted as Joint Global Coordinator and Joint Bookrunner in relation to the Private Placement in Lytix Biopharma AS and subsequent listing on Euronext Growth Oslo with a total transaction size of NOK 225 million.

Arctic acted as Joint Global Coordinator and Joint Bookrunner in relation to the Private Placement in Lytix Biopharma AS and subsequent listing on Euronext Growth Oslo with a total transaction size of NOK 225 million.

 

The first day of trading on Euronext Growth Oslo is expected to be on or about 14 June 2021.

 

We are grateful for the vote of confidence and congratulate on the successful transaction.

Latest news

  1. Arctic Securities -

    IMPORTANT NOTICE — ARCTICSAS

    Arctic Securities is not affiliated with "Arctic SAS" or www.arcticsas.com.

    We have been made aware that unknown parties are using the Arctic Securities name, logo and trademark in connection with investment offers directed at private individuals abroad.